Food and Drug Administration Drug Safety Podcast
FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib)
- Author: Podcast
- Narrator: Podcast
- Publisher: Podcast
- Duration: 0:04:00
- More information
Informações:
Synopsis
Listen to an audio podcast of the June 30, 2022, FDA Drug Safety Communication. Results from a clinical trial show a possible increased risk of death with Copiktra (active ingredient duvelisib) compared to another medicine to treat leukemia and lymphoma.
